Skip to main content

Advertisement

Log in

In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues

  • ORIGINAL ARTICLE
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Therapy guided by chemotherapy sensitivity and resistance assays may lead to rational treatment decisions. Paclitaxel, one of several new drugs for gastric carcinoma, has not been extensively evaluated by in vitro chemosensitivity tests.

Methods

Chemosensitivity testing by histoculture drug response assay (HDRA) was performed with fresh specimens of primary tumor from 113 patients with gastric carcinoma. The test was performed in medium containing paclitaxel at three different concentrations for the initial 45 samples. Correlations between the results of chemosensitivity testing, determined at the optimal concentration, and the patients' clinicopathologic factors and outcome were then assessed for all patients.

Results

By analyzing the initial 45 samples, 10 µg/ml was considered the optimal concentration of paclitaxel for this test. HDRA was successfully performed for 100 of 113 samples and chemosensitivity, calculated as the percentage of optical density of a tumor treated with anticancer drugs in relation to the optical density of the tumor cultured in the medium only, was distributed widely at this concentration. No significant correlation was observed between chemosensitivity and age, sex, clinical stage, histopathologic type, and outcome of patients with gastric carcinoma.

Conclusion

A histoculture drug response assay can now be performed to predict the chemosensitivity of paclitaxel at the concentration found in the current study. The accuracy of the assay to actually predict survival needs to be validated by a prospective clinical trial involving patients who have received paclitaxel in the postoperative adjuvant setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D Cunningham WH Alum SP Stenning et al. (2006) ArticleTitlePerioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Eng J Med 355 11–20 Occurrence Handle10.1056/NEJMoa055531 Occurrence Handle1:CAS:528:DC%2BD28Xms1Chsrw%3D

    Article  CAS  Google Scholar 

  2. B Neri G Cini F Andreoli et al. (2001) ArticleTitleRandomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up Br J Cancer 84 878–880 Occurrence Handle11286464 Occurrence Handle10.1054/bjoc.2000.1472 Occurrence Handle1:CAS:528:DC%2BD3MXktVaqurY%3D

    Article  PubMed  CAS  Google Scholar 

  3. L Cirera A Balil E Batiste-Alentorn et al. (1999) ArticleTitleRandomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer J Clin Oncol 17 3810–3815 Occurrence Handle10577853 Occurrence Handle1:CAS:528:DC%2BD3cXhsVCiuw%3D%3D

    PubMed  CAS  Google Scholar 

  4. JS Macdonald SR Smalley J Benedetti et al. (2001) ArticleTitleChemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725–730 Occurrence Handle11547741 Occurrence Handle10.1056/NEJMoa010187 Occurrence Handle1:STN:280:DC%2BD3Mvps1Cqug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. T Nakajima A Nashimoto M Kitamura et al. (1999) ArticleTitleAdjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial Lancet 354 273–277 Occurrence Handle10440302 Occurrence Handle10.1016/S0140-6736(99)01048-X Occurrence Handle1:CAS:528:DyaK1MXltFOlur4%3D

    Article  PubMed  CAS  Google Scholar 

  6. A Nashimoto T Nakajima H Furukawa et al. (2003) ArticleTitleRandomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1 J Clin Oncol 21 2282–2287 Occurrence Handle12805327 Occurrence Handle10.1200/JCO.2003.06.103 Occurrence Handle1:CAS:528:DC%2BD2cXpsVKjsrw%3D

    Article  PubMed  CAS  Google Scholar 

  7. I Miyashiro H Furukawa M Sasako et al. (2005) ArticleTitleNo survival benefit with adjuvant chemotherapy for serosa-positive gastric cancer: randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil in serosa-positive gastric cancer. Japan Clinical Oncology Group 9206-2 Proc ASCO-GI 84 4

    Google Scholar 

  8. K Iwao-Koizumi R Matoba N Ueno et al. (2005) ArticleTitlePrediction of docetaxel response in human breast cancer by gene expression profiling J Clin Oncol 23 422–431 Occurrence Handle15659489 Occurrence Handle10.1200/JCO.2005.09.078 Occurrence Handle1:CAS:528:DC%2BD2MXitVarsbw%3D

    Article  PubMed  CAS  Google Scholar 

  9. R Luthra TT Wu MG Luthra et al. (2006) ArticleTitleGene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation J Clin Oncol 24 259–267 Occurrence Handle16344314 Occurrence Handle10.1200/JCO.2005.03.3688 Occurrence Handle1:CAS:528:DC%2BD28XhtVKqtrs%3D

    Article  PubMed  CAS  Google Scholar 

  10. DJ Samson J Seidenfeld K Ziegler et al. (2004) ArticleTitleChemotherapy sensitivity and resistance assays: a systematic review J Clin Oncol 22 3618–3630 Occurrence Handle15289487 Occurrence Handle10.1200/JCO.2004.04.077 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWrsrg%3D

    Article  PubMed  CAS  Google Scholar 

  11. S Suda S Akiyama H Sekiguchi et al. (2002) ArticleTitleEvaluation of the histoculture drug response assay as a sensitivity test for anticancer agents Surgery Today 32 477–481 Occurrence Handle12107769 Occurrence Handle10.1007/s005950200080 Occurrence Handle1:CAS:528:DC%2BD38XlvVKgtro%3D

    Article  PubMed  CAS  Google Scholar 

  12. InstitutionalAuthorNameJapanese Gastric Cancer Association (1998) ArticleTitleJapanese classification of gastric carcinoma–2nd English edition Gastric Cancer 1 10–24 Occurrence Handle11957040 Occurrence Handle10.1007/PL00011681

    Article  PubMed  Google Scholar 

  13. S Maeda Y Saikawa T Kubota et al. (2003) ArticleTitleNo cross-resistance of Taxotere and Taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay Anticancer Res 23 314–3150

    Google Scholar 

  14. EK Rowinsky RC Donehower RJ Jones et al. (1988) ArticleTitleMicrotubule changes and cytotoxicity in leukemic cell lines treated with taxol Cancer Res 48 4093–4100 Occurrence Handle2898289 Occurrence Handle1:CAS:528:DyaL1cXkvVGrurc%3D

    PubMed  CAS  Google Scholar 

  15. H Kobayashi (2005) ArticleTitleCollagen gel droplet culture method to examine in vitro chemosensitivity Methods Mol Med 110 59–67 Occurrence Handle15901927 Occurrence Handle1:CAS:528:DC%2BD2MXktF2jur4%3D

    PubMed  CAS  Google Scholar 

  16. K Yamaguchi M Tada N Horikoshi et al. (2002) ArticleTitlePhase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer Gastric Cancer 5 90–95 Occurrence Handle12111584 Occurrence Handle10.1007/s101200200015 Occurrence Handle1:CAS:528:DC%2BD38XmslGlsbg%3D

    Article  PubMed  CAS  Google Scholar 

  17. Y Sakata A Ohtsu N Horikoshi et al. (1998) ArticleTitleLate phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715–1720 Occurrence Handle9893658 Occurrence Handle10.1016/S0959-8049(98)00211-1 Occurrence Handle1:CAS:528:DyaK1cXntlShurw%3D

    Article  PubMed  CAS  Google Scholar 

  18. H Nakanishi Y Mochizuki Y Kodera et al. (2003) ArticleTitleChemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line Cancer Sci 94 112–118 Occurrence Handle12708484 Occurrence Handle10.1111/j.1349-7006.2003.tb01361.x Occurrence Handle1:CAS:528:DC%2BD3sXisFekuro%3D

    Article  PubMed  CAS  Google Scholar 

  19. N Ohashi Y Kodera H Nakanishi et al. (2005) ArticleTitleEfficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice Int J Oncol 27 637–644 Occurrence Handle16077911 Occurrence Handle1:CAS:528:DC%2BD2MXpvVWmt7g%3D

    PubMed  CAS  Google Scholar 

  20. S Abe T Kubota SW Matsuzaki et al. (1999) ArticleTitleChemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers Anticancer Res 19 4581–4586 Occurrence Handle10650814 Occurrence Handle1:CAS:528:DC%2BD3cXns1Onsg%3D%3D

    PubMed  CAS  Google Scholar 

  21. A Tsuburaya J Sakamoto S Morita et al. (2005) ArticleTitleA randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S-1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial Jpn J Clin Oncol 35 672–675 Occurrence Handle16275676 Occurrence Handle10.1093/jjco/hyi179

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuhiro Kodera.

About this article

Cite this article

Kodera, Y., Ito, S., Fujiwara, M. et al. In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues. Int J Clin Oncol 11, 449–453 (2006). https://doi.org/10.1007/s10147-006-0618-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-006-0618-x

Key words

Navigation